230 related articles for article (PubMed ID: 32561426)
1. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
Liu Y; Jin G; Sun J; Wang X; Guo L
Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study.
Wu Q; Ren J; Wu X; Wang G; Gu G; Liu S; Wu Y; Hu D; Zhao Y; Li J
J Crit Care; 2014 Jun; 29(3):362-6. PubMed ID: 24405656
[TBL] [Abstract][Full Text] [Related]
3. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial).
Zhou Z; Feng T; Xie Y; Huang P; Xie H; Tian R; Qian B; Wang R
BMC Infect Dis; 2019 Sep; 19(1):780. PubMed ID: 31492102
[TBL] [Abstract][Full Text] [Related]
4. [The role of recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: a clinical study].
Dong F; Ma N; Chang S; Yang H; Gao M; Liu Q; Sun X; Liang M; Sun R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1445-1449. PubMed ID: 33541495
[TBL] [Abstract][Full Text] [Related]
5. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
[TBL] [Abstract][Full Text] [Related]
6. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia.
Wang X; Bi H; Liu L; Liu Y; Yin L; Yao J; Yu J; Tao W; Wei Y; Li Y; Yin L; Mu H; Du Y; Zhou Z
Platelets; 2023 Dec; 34(1):2271568. PubMed ID: 37941414
[TBL] [Abstract][Full Text] [Related]
8. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia.
Wang S; Yang R; Zou P; Hou M; Wu D; Shen Z; Lu X; Li Y; Chen X; Niu T; Sun H; Yu L; Wang Z; Zhang Y; Chang N; Zhang G; Zhao Y
Int J Hematol; 2012 Aug; 96(2):222-8. PubMed ID: 22753022
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human thrombopoietin alleviates infection-associated thrombocytopenia: a retrospective study in senile patients.
Lin J; Zhu H; Li S; Fan H; Lu X
Clin Appl Thromb Hemost; 2015 Jan; 21(1):19-24. PubMed ID: 23637005
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
Xu YH; Chen ZW; Ye XY; Lu S
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis.
Wang Y; Wang Z; Wu L; Zhang J; Wang J; Yan L
Ann Hematol; 2013 Dec; 92(12):1695-9. PubMed ID: 23778995
[TBL] [Abstract][Full Text] [Related]
12. [Effect of recombinant human thrombopoietin on endotoxin-induced thrombocytopenia in mice].
Jiang J; Wang B; Yu X; Xu H; Wang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1108-1112. PubMed ID: 31657334
[TBL] [Abstract][Full Text] [Related]
13. A multicentre double-blind, double-dummy, randomised study of recombinant human thrombopoietin versus eltrombopag in the treatment of immune thrombocytopenia in Chinese adult patients.
Mei H; Xu M; Yuan G; Zhu F; Guo J; Huang R; Qin J; Lv T; Qin F; Cai H; Yin P; Qin T; Hu Y
Br J Haematol; 2021 Dec; 195(5):781-789. PubMed ID: 34528239
[TBL] [Abstract][Full Text] [Related]
14. A Network Meta-Analysis of Two Doses of Recombinant Human Thrombopoietin for Treating Sepsis-Related Thrombocytopenia.
Chen D; Hou Y; Wei C; Cai X
Int J Clin Pract; 2022; 2022():2124019. PubMed ID: 36683598
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human thrombopoietin therapy for primary immune thrombocytopenia in pregnancy: a retrospective comparative cohort study.
Lin J; Wang TF; Huang MJ; Huang HB; Chen PF; Zhou Y; Dai WC; Zhou L; Feng XS; Wang HL
BMC Pregnancy Childbirth; 2023 Nov; 23(1):820. PubMed ID: 38012579
[TBL] [Abstract][Full Text] [Related]
16. A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
Chen M; Li L; Xia Q; Chen X; Liao Z; Wang C; Shen B; Zhou M; Zhang Q; Zhang Y; Qian L; Yuan X; Wang Z; Xue C; An X; Liu B; Gu K; Hou M; Wang X; Wang W; Li E; Zhong J; Cheng J; Shu Y; Yang N; Wang H; Yang R; Liu T; Deng T; Ma F; Liao W; Qiu W; Chen Y; Chen X; Zhang M; Xu R; Li X; Feng J; Ba Y; Shi Y
Cancer; 2024 Apr; 130(S8):1524-1538. PubMed ID: 38515388
[TBL] [Abstract][Full Text] [Related]
17. Administration of recombinant human thrombopoietin is associated with alleviated thrombocytopenia in adult intensive care unit patients with pneumonia: A single-center retrospective study.
Chen B; Xuan J; Wu F; Shi N; Dai J; Cai S; An S; Huang Q; Huang X; Chen Z; Zeng Z
Front Pharmacol; 2022; 13():1007719. PubMed ID: 36299903
[No Abstract] [Full Text] [Related]
18. Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.
Liu X; Bai Y; Wang T; Song Y; Sun F; Xia R; Zhu F; Ma J; Lu Q; Ye X; Zhan X; Li L; Guo X; Cheng S; Li Y; Guo Z; Chen Y; Qian S; Qin L; Zhang Q; Cao S; Yang R
Platelets; 2023 Dec; 34(1):2157806. PubMed ID: 36597010
[TBL] [Abstract][Full Text] [Related]
19. [Clinical Analysis of Recombinant Human Thrombopoietin for Treatment of 46 Adult Patients with Newly Diagnosed Primary Immune Thrombocytopenia].
Wang M; Liu YF; Sun H; Xie XS; Ma J; Gan SL; Dong YJ; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):531-5. PubMed ID: 27151024
[TBL] [Abstract][Full Text] [Related]
20. [Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients].
Xu YH; Cheng BJ; Lu S; Jian H; Zhou Z; Chen ZW; Ye XY
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):395-9. PubMed ID: 21875475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
